Fred’s Pharmacy Declares Quarterly Cash Dividend of $0.06 Per Share

MEMPHIS, Tenn.--(BUSINESS WIRE)-- Fred’s, Inc. (NASDAQ: FRED) today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share. The dividend is payable on June 15, 2017, to shareholders of record as of June 1, 2017.

About Fred's Pharmacy

Tracing its history back to an original store in Coldwater, Mississippi, opened in 1947, today Fred’s Pharmacy is headquartered in Memphis, Tennessee, and operates 601 pharmacy and general merchandise stores and three specialty pharmacy-only locations, including 14 franchised Fred’s Pharmacy locations. With a unique store format and strategy that combines the best elements of a healthcare-focused drug store with a value-focused retailer, Fred’s Pharmacy stores offer more than 12,000 frequently purchased items that address the healthcare and everyday needs of its customers and patients. This includes nationally recognized brands, proprietary Fred’s Pharmacy label products, and a full range of value-priced selections. The company has two distribution centers, one in Memphis, Tennessee, and Dublin, Georgia.

On December 20, 2016, Fred's Pharmacy announced that it signed an agreement with Walgreens Boots Alliance, Inc. (NASDAQ: WBA) and Rite Aid Corporation (NYSE: RAD) to purchase 865 stores and certain assets related to store operations located across the eastern and western United States for $950 million in cash. Closing of the transaction is conditioned on the completion of Walgreens Boots Alliance's proposed acquisition of Rite Aid, approval by the Federal Trade Commission, as well as customary regulatory approvals and closing conditions.

For more information about the Company, visit Fred's website at www.fredsinc.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170522006270/en/

Fred’s, Inc.
Rick Hans, 901-238-2232
Executive Vice President,
Chief Financial Officer and Secretary

Source: Fred’s, Inc.

You May Also Be Interested In

• Exclusive: National Vision CEO on traffic, ticket growth and the digital shift
• Sivers Semiconductors Makes Changes to Senior Leadership Team for Next Phase of Commercial Growth
• Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026